• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Outcome of surgical resection for chest wall recurrence in breast cancer patients.

作者信息

Toi M, Tanaka S, Bando M, Hayashi K, Tominaga T

机构信息

Department of Surgery, Tokyo, Metropolitan Komogome Hospital, Japan.

出版信息

J Surg Oncol. 1997 Jan;64(1):23-6. doi: 10.1002/(sici)1096-9098(199701)64:1<23::aid-jso5>3.0.co;2-r.

DOI:10.1002/(sici)1096-9098(199701)64:1<23::aid-jso5>3.0.co;2-r
PMID:9040796
Abstract

BACKGROUND

Although recurrent breast cancer is a systemic disease, there might be several exceptions where local treatment has a favorable outcome.

METHODS

From 1989 to 1996, 15 patients underwent full thickness chest wall resection, supported by peri- and postoperative systemic treatments for patients with isolated chest wall recurrences, including soft tissue local recurrence and parasternal lymph node metastasis.

RESULTS

The 5-year survival rate after surgical removal was 47%. Patients with > 5-year disease-free intervals (DFI) after mastectomy showed a long survival after chest wall resection. Local failures appeared in four cases whose surgical margins were positive. No serious complication except one pyothorax occurred after surgery.

CONCLUSIONS

It is suggested that surgical treatment with a full thickness chest wall resection might have a favorable prognosis for selected patients with solitary lesion and long DFI.

摘要

相似文献

1
Outcome of surgical resection for chest wall recurrence in breast cancer patients.
J Surg Oncol. 1997 Jan;64(1):23-6. doi: 10.1002/(sici)1096-9098(199701)64:1<23::aid-jso5>3.0.co;2-r.
2
[Full thickness chest wall resection for recurrent breast cancer with reference to prognostic factors].
Nihon Geka Gakkai Zasshi. 1993 Jul;94(7):745-50.
3
[Evaluation of chest wall resection in the patients with breast cancer involving chest wall].
Nihon Geka Gakkai Zasshi. 1991 Dec;92(12):1708-12.
4
Surgical treatment for chest wall recurrence of breast cancer.乳腺癌胸壁复发的外科治疗。
Eur J Cancer. 1992;28A(6-7):1059-62. doi: 10.1016/0959-8049(92)90456-c.
5
Full thickness chest wall resection for recurrent breast carcinoma involving the bony chest wall.对累及骨性胸壁的复发性乳腺癌行全层胸壁切除术。
Cancer. 1975 Mar;35(3):567-73. doi: 10.1002/1097-0142(197503)35:3<567::aid-cncr2820350302>3.0.co;2-0.
6
Breast cancer recurrence after immediate reconstruction: patterns and significance.即刻乳房重建术后的乳腺癌复发:模式与意义。
Plast Reconstr Surg. 2003 Feb;111(2):712-20; discussion 721-2. doi: 10.1097/01.PRS.0000041441.42563.95.
7
Clinical course of breast cancer patients with isolated sternal and full-thickness chest wall recurrences treated with and without radical surgery.乳腺癌患者孤立性胸骨和全层胸壁复发经根治性手术与非根治性手术治疗的临床病程。
Ann Surg Oncol. 2013 Dec;20(13):4153-60. doi: 10.1245/s10434-013-3202-4.
8
Chest wall resection for internal mammary lymph node metastases of breast cancer.乳腺癌内乳淋巴结转移的胸壁切除术。
Breast. 2009 Apr;18(2):94-9. doi: 10.1016/j.breast.2009.01.005. Epub 2009 Feb 24.
9
Surgical resection of secondary chest wall tumors.继发性胸壁肿瘤的手术切除
Thorac Cardiovasc Surg. 2005 Aug;53(4):234-9. doi: 10.1055/s-2005-837649.
10
Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.乳房切除术后乳腺癌的局部区域复发:总是致命事件吗?单因素和多因素分析结果
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63. doi: 10.1016/s0360-3016(96)00556-1.

引用本文的文献

1
Chest wall resections for advanced breast cancer: a narrative review.晚期乳腺癌胸壁切除术:一项叙述性综述。
J Thorac Dis. 2024 Oct 31;16(10):7182-7191. doi: 10.21037/jtd-23-1432. Epub 2024 Oct 10.
2
Surgical reduction in chest wall disease to prolong survival in breast cancer patients: a retrospective study.手术减轻胸壁疾病以延长乳腺癌患者生存期:一项回顾性研究。
Gland Surg. 2022 Jun;11(6):1015-1025. doi: 10.21037/gs-22-246.
3
Arctigenin inhibits human breast cancer cell proliferation, migratory and invasive abilities and epithelial to mesenchymal transition by targeting 4EBP1.
牛蒡子苷元通过靶向4EBP1抑制人乳腺癌细胞的增殖、迁移和侵袭能力以及上皮-间质转化。
Exp Ther Med. 2021 Jun;21(6):547. doi: 10.3892/etm.2021.9979. Epub 2021 Mar 24.
4
Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence.77 例孤立性乳腺癌复发患者行根治性胸壁切除术的预后因素分析。
Ann Surg Oncol. 2009 Dec;16(12):3414-21. doi: 10.1245/s10434-009-0662-7.